Table 2.

 Association between H. pylori infection and risk of developing diabetes (2002–2012)

	All participants (n = 2085)		Participants without IFG (n = 2043)
	RR (95% CI)	p value	RR (95% CI)	p value
Events No.	259		235
Unadjusted	0.85 (0.68, 1.07)	0.176	0.86 (0.67, 1.09)	0.215
Model 1	0.86 (0.68, 1.08)	0.200	0.86 (0.67, 1.10)	0.223
Model 2	0.78 (0.63, 0.97)	0.025	0.80 (0.64, 1.01)	0.059
Model 3	0.78 (0.63, 0.97)	0.025	0.79 (0.63, 0.99)	0.043
Model 4	0.78 (0.63, 0.97)	0.022	0.80 (0.64, 1.01)	0.057

Model 1: Sex- and age-adjusted

Model 2: Model 1 + BMI (continuous variable), systolic BP (per 5 mmHg, continuous variable), HDL-C (continuous variable), triacylglycerol (< 1.7 or ≥ 1.7 mmol/l), FBG (continuous variable), lipid-lowering therapy (no or yes)

Model 3: Model 2 + Hs-CRP (< 3 or ≥ 3 mg/l)

Model 4: Model 3 + level of education (≤ 12 or > 12 years)

No., number